XML 19 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Stock incentive plan (Tables)
3 Months Ended
Mar. 31, 2020
Stock incentive plan  
Allocation of stock-based compensation expenses

Non-cash stock-based compensation expense recognized in the accompanying condensed statements of operations relating to both stock options, restricted stock awards, and restricted stock units for the three months ended March 31, 2020 and 2019 was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

March 31, 

 

 

    

2020

    

2019

    

Research and development

 

$

456

 

$

421

 

General and administrative

 

 

1,875

 

 

1,579

 

Total stock‑based compensation expense

 

$

2,331

 

$

2,000

 

 

Schedule of restricted stock unit activity

The table below summarizes activity related to restricted stock units (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

    

 

    

Weighted‑

 

 

 

 

average

 

 

 

 

grant date

 

 

 

 

fair value

 

 

Shares

 

per share

Unvested as of December 31, 2019

 

1,032

 

$

3.63

Issued

 

 —

 

$

 —

Vested

 

(6)

 

 

3.63

Forfeited and canceled

 

(59)

 

 

3.63

Unvested as of March 31, 2020

 

967

 

$

3.63

 

Summary of stock option activity

The table below summarizes activity related to stock options (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted‑

    

 

 

 

 

 

 

Weighted‑

 

average

 

 

 

 

 

 

 

average

 

remaining

 

Aggregate

 

 

 

 

exercise

 

contractual

 

intrinsic

Options

 

Shares

 

price

 

term

 

value

Outstanding, December 31, 2019

 

4,798

 

$

8.75

 

8.29

 

$

1,159

Granted

 

1,939

 

 

3.09

 

  

 

 

  

Exercised

 

(104)

 

 

2.34

 

 

 

 

 

Forfeited and canceled

 

(214)

 

 

6.12

 

  

 

 

  

Outstanding, March 31, 2020

 

6,419

 

$

7.23

 

8.48

 

$

102

Vested and expected to vest at March 31, 2020

 

6,419

 

$

7.23

 

8.48

 

$

102

Exercisable at March 31, 2020

 

2,439

 

$

6.96

 

7.45

 

$

100